Core A will provide leadership, management, organizational structure, fiscal oversight, and scientific direction to the Penn Mental Health AIDS Research Center (PMHARC), enabling it to fulfill its core mission to transform how people with both mental illness and HIV/AIDS (mental illness/AIDS) are treated and managed, an explicit focus not currently pursued by any other center in the country. The Center and Gore A will be led by a Director and two Go-Directors with exceptional and complementary strengths and experience in administration, research, and training and in the study of comorbid mental illness/AIDS. PMHARG will be located in an optimal intellectual and resource environment, which encompasses robust and well-regarded mental illness and AIDS research communities on the University of Pennsylvania and Children's Hospital of Philadelphia contiguous campuses. The Center, through Gore A, will optimize psychiatric, behavioral, and medical outcomes for those suffering from comorbid mental illness/AIDS and elucidate the biological, psychological, and behavioral mechanisms underlying these combined illnesses and treatments. Gore A will create an interactive environment that fosters communication, collaboration, and synergy among Center components and participants, as well as with the relevant schools, departments, centers, and institutes at Penn/CHOP and with other NIMH AIDS Research Centers. This proactive Core will be engaged and responsible for: 1) coordinating interdisciplinary and collaborative mental health and AIDS research activities;2) encouraging, supporting, and mentoring new, established, and transitional investigators to focus on comorbid mental illness/AIDS, and related comorbidities;3) developing vibrant and responsive Strategic Planning, Monitoring, and Evaluation Processes and comprehensive Policies and Procedures;4) managing fiscal matters;5) conducting educational and community outreach programs;6) fostering national linkages among other NIMH AIDS Research Centers;and 7) establishing an active Community Advisory Board (GAB). Core A will include the Center Director, 2 Co-Directors, Executive Committee (EC), Internal Advisory Board (lAB), External Advisory Committee (EAC), Gross-Talk Committee, and CAB. This structure of Gore A is explicitly intended to allow for continuous monitoring and evaluation of PMHARC functioning in order to optimize efficiencies and responsiveness.

Public Health Relevance

Gore A will provide leadership, management, organizational structure, fiscal oversight, and scientific direction to the proposed Center, enabling it to transform how people with both mental illness and HIV/AIDS are treated and managed, an explicit focus not currently pursued by any other center in the country. The Center, through Gore A, will optimize psychiatric, behavioral, and medical outcomes for those suffering from comorbid mental illness/AIDS and elucidate the biological, psychological, and behavioral mechanisms underlying these combined illnesses and treatments

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH097488-02
Application #
8670022
Study Section
Special Emphasis Panel (ZMH1-ERB-M)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
2
Fiscal Year
2014
Total Cost
$303,433
Indirect Cost
$113,787
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Buckingham, Lindsey; Becher, Julie; Voytek, Chelsea D et al. (2017) Going social: Success in online recruitment of men who have sex with men for prevention HIV vaccine research. Vaccine 35:3498-3505
Ransome, Yusuf; Dean, Lorraine T; Crawford, Natalie D et al. (2017) How Do Social Capital and HIV/AIDS Outcomes Geographically Cluster and Which Sociocontextual Mechanisms Predict Differences Across Clusters? J Acquir Immune Defic Syndr 76:13-22
Vujkovic, Marijana; Bellamy, Scarlett L; Zuppa, Athena F et al. (2017) Brief Report: CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-Treated HIV-Infected Patients in Botswana. J Acquir Immune Defic Syndr 75:488-491
Tuluc, Florin; Spitsin, Sergei; Tustin, Nancy B et al. (2017) Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8?Tscm Cells in Children with HIV Receiving Raltegravir. AIDS Res Hum Retroviruses 33:133-142
German, Danielle; Brady, Kathleen; Kuo, Irene et al. (2017) Characteristics of Black Men Who Have Sex With Men in Baltimore, Philadelphia, and Washington, D.C.: Geographic Diversity in Socio-Demographics and HIV Transmission Risk. J Acquir Immune Defic Syndr 75 Suppl 3:S296-S308
Harrison, Joseph D; Dochney, Jessica A; Blazekovic, Sonja et al. (2017) The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV. J Neurovirol 23:550-557
Gross, Robert; Bellamy, Scarlett L; Ratshaa, Bakgaki et al. (2017) CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in Botswana. AIDS 31:2107-2113
McLean, Carmen P; Gay, Natalie G; Metzger, David A et al. (2017) Psychiatric Symptoms and Barriers to Care in HIV-Infected Individuals Who Are Lost to Care. J Int Assoc Provid AIDS Care 16:423-429
Brickman, Cristina; Propert, Kathleen J; Voytek, Chelsea et al. (2017) Association Between Depression and Condom Use Differs by Sexual Behavior Group in Patients with HIV. AIDS Behav 21:1676-1683
Opondo, Philip R; Ho-Foster, Ari R; Ayugi, James et al. (2017) HIV Prevalence Among Hospitalized Patients at the Main Psychiatric Referral Hospital in Botswana. AIDS Behav :

Showing the most recent 10 out of 63 publications